Advances in nanomedicine, including early cancer detection, targeted drug delivery, and
personalized approaches to cancer treatment are on the rise. For example, targeted drug …

Cancer is a leading cause of death worldwide. Currently available therapies are inadequate
and spur demand for improved technologies. Rapid growth in nanotechnology towards the …

Today, in diverse medical and clinical fields, including cancer treatment, nanoscience has
evolved and evolved. Cancer and its forms, on the other hand, have been rumored and …

Multidrug resistance (MDR) is a major cause of failure in cancer chemotherapy. P-
glycoprotein (P-gp), a promiscuous drug efflux pump, has been extensively studied for its …

Cancer nanotherapeutics are progressing at a steady rate; research and development in the
field has experienced an exponential growth since early 2000's. The path to the …

Abstract Poly (ethylene glycol)(PEG) is the most used polymer and also the gold standard for
stealth polymers in the emerging field of polymer‐based drug delivery. The properties that …

The delivery of drugs through targeted nanocarriers that are internalized by cells provides
an alternative route to diffusion of drugs into cells. Growth factor or vitamin interactions with …

Advances in polymer science have led to the development of novel drug delivery systems.
Some polymers are obtained from natural resources and then chemically modified for …

Cancer is a highly complex disease to understand, because it entails multiple cellular
physiological systems. The most common cancer treatments are restricted to chemotherapy …

The transfer of polymer–protein conjugates into routine clinical use, and the clinical
development of polymer–anticancer-drug conjugates, both as single agents and as …